Most bought healthcare stocks in Q2 2017
See which Healthcare stocks institutional investors increased the most in Q2 2017, measured as net growth in reported share positions from Q1 2017 into Q2 2017. Notable additions at the top of this list include ELI LILLY & CO (LLY), BRISTOL-MYERS SQUIBB CO (BMY), PFIZER INC (PFE), GILEAD SCIENCES INC (GILD). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 9,695,827 | $757.53M | 0 | 5 | 0 | 0 | 5 |
| BMY | BRISTOL-MYERS SQUIBB CO | 6,794,256 | $428.02M | 0 | 5 | 3 | 1 | 10 |
| PFE | PFIZER INC | 4,204,660 | $128.63M | 1 | 5 | 6 | 2 | 14 |
| GILD | GILEAD SCIENCES INC | 3,993,758 | $391.86M | 0 | 7 | 4 | 1 | 13 |
| DHR | DANAHER CORP | 2,008,691 | $168.15M | 0 | 5 | 2 | 0 | 10 |
| OPK | OPKO HEALTH INC | 1,615,691 | $10.63M | 1 | 0 | 0 | 0 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | 1,485,291 | $277.01M | 1 | 0 | 3 | 0 | 4 |
| AMGN | AMGEN INC | 1,396,313 | $262.53M | 1 | 2 | 5 | 0 | 10 |
| CAH | CARDINAL HEALTH INC | 1,394,108 | $79.70M | 0 | 5 | 2 | 0 | 7 |
| MOH | MOLINA HEALTHCARE INC | 1,309,382 | $114.16M | 1 | 0 | 1 | 0 | 2 |
| HALO | HALOZYME THERAPEUTICS INC | 948,701 | $11.12M | 1 | 0 | 1 | 0 | 3 |
| CERS | CERUS CORP | 926,247 | $705.00K | 0 | 1 | 1 | 0 | 2 |
| EXEL | EXELIXIS INC | 881,050 | $26.31M | 0 | 1 | 0 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | 824,900 | $11.29M | 0 | 1 | 0 | 0 | 1 |
| THC | TENET HEALTHCARE CORP | 778,655 | $15.06M | 1 | 0 | 0 | 0 | 1 |
| GRFS | GRIFOLS SA-ADR | 746,048 | -$25.45M | 0 | 2 | 0 | 0 | 2 |
| WAT | WATERS CORP | 726,201 | $286.68M | 0 | 3 | 1 | 0 | 4 |
| CTLT | CATALENT INC | 669,490 | $25.75M | 1 | 1 | 0 | 0 | 2 |
| AKBA | AKEBIA THERAPEUTICS INC | 639,033 | $11.18M | 0 | 1 | 0 | 0 | 1 |
| SYK | STRYKER CORP | 568,874 | $136.15M | 1 | 3 | 1 | 1 | 5 |
| AMRN | AMARIN CORP PLC -ADR | 560,478 | $3.69M | 0 | 1 | 0 | 0 | 1 |
| PRGO | Perrigo Company PLC | 536,708 | $81.56M | 2 | 1 | 1 | 0 | 4 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 533,737 | $60.97M | 1 | 2 | 0 | 0 | 3 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 525,748 | $5.24M | 2 | 0 | 0 | 0 | 2 |
| CPRX | CATALYST PHARMACEUTICALS INC | 509,400 | $1.72M | 0 | 1 | 0 | 0 | 1 |
| NKTR | NEKTAR THERAPEUTICS | 500,500 | $7.17M | 0 | 1 | 0 | 0 | 1 |
| MDXG | MIMEDX GROUP INC | 485,400 | $11.22M | 1 | 0 | 1 | 0 | 2 |
| EXAS | EXACT SCIENCES CORP | 457,300 | $20.30M | 0 | 1 | 0 | 0 | 1 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 443,800 | $8.72M | 0 | 1 | 0 | 0 | 1 |
| ABBV | ABBVIE INC | 422,786 | $56.26M | 1 | 4 | 4 | 2 | 12 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 374,793 | $63.19M | 2 | 2 | 3 | 0 | 8 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 374,164 | $606.00K | 1 | 0 | 0 | 0 | 1 |
| IDXX | IDEXX LABORATORIES INC | 342,133 | $92.41M | 0 | 1 | 1 | 0 | 3 |
| PDCO | PATTERSON COS INC | 336,856 | $44.49M | 0 | 2 | 1 | 0 | 4 |
| UTHR | UNITED THERAPEUTICS CORP | 331,400 | $40.13M | 0 | 1 | 0 | 0 | 1 |
| WST | WEST PHARMACEUTICAL SERVICES | 314,500 | $29.78M | 0 | 1 | 0 | 0 | 1 |
| OMI | OWENS & MINOR INC | 305,616 | $5.49M | 0 | 1 | 1 | 0 | 2 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 288,500 | $499.00K | 0 | 1 | 0 | 0 | 1 |
| BKD | BROOKDALE SENIOR LIVING INC | 288,370 | $6.89M | 1 | 0 | 1 | 0 | 2 |
| EDIT | EDITAS MEDICINE INC | 280,265 | -$6.04M | 0 | 1 | 0 | 0 | 2 |
| CCRN | CROSS COUNTRY HEALTHCARE INC | 273,914 | $3.54M | 1 | 0 | 0 | 0 | 1 |
| ILMN | ILLUMINA INC | 254,842 | $44.57M | 1 | 0 | 1 | 0 | 3 |
| MCRB | SERES THERAPEUTICS INC | 244,776 | $2.79M | 0 | 2 | 0 | 0 | 2 |
| RDNT | RADNET INC | 219,900 | $2.64M | 0 | 1 | 0 | 0 | 1 |
| MASI | MASIMO CORP | 191,400 | $16.56M | 0 | 1 | 0 | 0 | 1 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 187,600 | $8.40M | 0 | 1 | 0 | 0 | 1 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 185,300 | $408.00K | 0 | 1 | 0 | 0 | 1 |
| PODD | INSULET CORP | 179,500 | $10.43M | 0 | 1 | 0 | 0 | 1 |
| CTMX | CYTOMX THERAPEUTICS INC | 176,100 | $2.31M | 0 | 1 | 0 | 0 | 1 |
| ANGO | ANGIODYNAMICS INC | 167,510 | $2.14M | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2017
What are the most bought Healthcare stocks in Q2 2017?
The most bought healthcare stocks in Q2 2017 are those with the largest increase in reported share counts across institutional investors compared to Q1 2017, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2017?
Among filers in this sector, net additions were largest in companies such as ELI LILLY & CO (LLY), BRISTOL-MYERS SQUIBB CO (BMY), PFIZER INC (PFE), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2017).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.